Technical Analysis for INO - Inovio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 8.91 -3.05% -0.28
INO closed down 3.05 percent on Monday, March 8, 2021, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical INO trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish -3.05%
Lizard Bullish Bullish Day Trade Setup -3.05%
Doji - Bullish? Reversal -3.05%
Lower Bollinger Band Walk Weakness -3.05%
Older End-of-Day Signals for INO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lizard Bullish Entry about 12 hours ago
Hammer Candlestick Entry about 12 hours ago
Rose Above Previous Day's High about 12 hours ago
Up 2% about 12 hours ago
Up 1% about 12 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inovio Pharmaceuticals, Inc. Description

Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company's DNA-based SynCon technology enables the design of vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company's clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus, hepatitis B virus, human immunodeficiency virus, and malaria vaccines. It is also advancing preclinical research for a seasonal/pandemic influenza vaccine, as well as other products. Inovio Pharmaceuticals, Inc. has collaboration and license agreements with VGX International, Merck, and ChronTech. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Infectious Diseases Cancers Prostate Cancer Clinical Research Influenza Coronavirus Hepatitis B Vaccine Vaccination Leukemia Novi Hepatitis C Immunodeficiency Hepatitis B Virus Hepatitis C Virus Influenza Vaccine Virus Malaria Papillomavirus Virology Cervical Cancer Avian Influenza Electroporation Seasonal/Pandemic Influenza Universal Flu Vaccine

Is INO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.79
52 Week Low 5.13
Average Volume 16,842,430
200-Day Moving Average 13.94
50-Day Moving Average 11.18
20-Day Moving Average 12.12
10-Day Moving Average 10.47
Average True Range 1.28
ADX 27.02
+DI 19.72
-DI 27.86
Chandelier Exit (Long, 3 ATRs ) 12.24
Chandelier Exit (Short, 3 ATRs ) 12.25
Upper Bollinger Band 15.93
Lower Bollinger Band 8.31
Percent B (%b) 0.08
BandWidth 62.87
MACD Line -0.75
MACD Signal Line -0.21
MACD Histogram -0.5397
Fundamentals Value
Market Cap 1.51 Billion
Num Shares 169 Million
EPS -1.22
Price-to-Earnings (P/E) Ratio -7.33
Price-to-Sales 803.76
Price-to-Book 6.50
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.75
Resistance 3 (R3) 9.83 9.64 9.61
Resistance 2 (R2) 9.64 9.42 9.59 9.56
Resistance 1 (R1) 9.27 9.29 9.18 9.19 9.51
Pivot Point 9.08 9.08 9.03 9.04 9.08
Support 1 (S1) 8.71 8.86 8.62 8.63 8.31
Support 2 (S2) 8.52 8.73 8.48 8.26
Support 3 (S3) 8.16 8.52 8.21
Support 4 (S4) 8.07